These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6799827)

  • 21. Neuropeptides and central nervous system injury. Clinical implications.
    Faden AI
    Arch Neurol; 1986 May; 43(5):501-4. PubMed ID: 2870700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRH and diseases of the motor system.
    Munsat TL; Lechan R; Taft JM; Jackson IM; Reichlin S
    Ann N Y Acad Sci; 1989; 553():388-98. PubMed ID: 2497682
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropeptides and spinal cord injury.
    Faden AI; Jacobs TP; Holaday JW
    Adv Biochem Psychopharmacol; 1982; 33():131-8. PubMed ID: 6812392
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
    Prange AJ; Wilson IC
    Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat.
    Hashimoto T; Fukuda N
    Jpn J Pharmacol; 1990 Aug; 53(4):479-86. PubMed ID: 2120495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy in spinal cord injury: a critical review of recent developments.
    Faden AI
    Clin Neuropharmacol; 1987 Jun; 10(3):193-204. PubMed ID: 2842048
    [No Abstract]   [Full Text] [Related]  

  • 27. Variation of pituitary thyrotropin reserve with different dosages of thyrotropin-releasing hormine (TRH) -- mode of failure of pituitary thyrotropin reserve.
    Sakoda M; Mori H; Tateiwa M; Kusaka T; Fukuda T
    Kobe J Med Sci; 1976 Jun; 22(2):81-9. PubMed ID: 827655
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathophysiology of spinal cord injury.
    Eidelberg E
    Radiol Clin North Am; 1977 Aug; 15(2):241-6. PubMed ID: 329347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical observations on therapeutic applications of thyrotropin-releasing hormone (TRH).
    Sakoda M; Mori H; Yamada A; Kusaka T; Tateiwa M
    Kobe J Med Sci; 1974 Jun; 20(2):65-81. PubMed ID: 4218287
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
    Faden AI; Yum SW; Lemke M; Vink R
    J Pharmacol Exp Ther; 1990 Nov; 255(2):608-14. PubMed ID: 2123006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New therapeutic possiblities in depression: the thyrotropin releasing hormone factor].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias L; Hernández Herreros M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1974 Mar; 2(2):91-102. PubMed ID: 4211532
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of glucocorticosteroids in treatment of acute spinal cord injury.
    Savitsky E
    West J Med; 1996 Jan; 164(1):69-70. PubMed ID: 8779213
    [No Abstract]   [Full Text] [Related]  

  • 34. Spinal cord injury and glucocortical steroid therapy: good news and bad.
    Ducker TB; Spengler DM; Balderston R; Keller T; Benson D; Kitahara H; Blumenkopf B; Kostuik J; Brisson PM; Krag M
    J Spinal Disord; 1990 Dec; 3(4):433-5; discussion 436-7. PubMed ID: 2134462
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled thyrotropin-releasing hormone for treatment of neuropsychiatric disorders.
    Lehrer S
    J Clin Psychopharmacol; 2014 Apr; 34(2):288-90. PubMed ID: 24135844
    [No Abstract]   [Full Text] [Related]  

  • 36. New pharmacologic approaches to acute spinal cord injury.
    Rhoney DH; Luer MS; Hughes M; Hatton J
    Pharmacotherapy; 1996; 16(3):382-92. PubMed ID: 8726596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin-releasing hormone and dementia.
    Sunderland T; Mellow AM; Gross M; Cohen RM; Tariot PN; Newhouse PA; Murphy DL
    Am J Psychiatry; 1986 Oct; 143(10):1318. PubMed ID: 3094388
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    van der Vis-Melsen MJ; Weiner JD
    Lancet; 1972 Dec; 2(7792):1415. PubMed ID: 4118700
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological strategies in CNS trauma.
    Faden AI; Salzman S
    Trends Pharmacol Sci; 1992 Jan; 13(1):29-35. PubMed ID: 1311880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D; Jackson IM
    Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.